Back to mobile site

More on CNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (0.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Context Therapeutics (NQ:CNTX)
Delayed: 0.37 -0.01 (2.63%)
Prev. Close $0.38  
Open$0.39 
52 Wk High$ 
52 Wk Low$ 
Day High$0.40 
Day Low$0.37 
P/E N/A  
EPS$ 
Volume1,209,241 

Friends, Peers and Foes (?): SKYE, NEOG, BCAB, IMNM, ONCY (more...)

Sep 9, 2026 07:30 AM Context Therapeutics doses first patient in CT-202 Phase 1 trial
Sep 9, 2026 07:30 AM Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
Aug 14, 2026 04:07 PM Form SCHEDULE 13G/A Context Therapeutics Filed by: MPM BioImpact LLC
Aug 12, 2026 04:31 PM Form SCHEDULE 13G/A Context Therapeutics Filed by: Blue Owl Capital Holdings LP
Aug 6, 2026 02:45 AM Context Therapeutics Inc. (CNTX) Misses Q2 EPS by 6c
Aug 5, 2026 04:21 PM Form 8-K Context Therapeutics For: Aug 05
Aug 5, 2026 04:14 PM Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress
Aug 5, 2026 04:14 PM Form 10-Q Context Therapeutics For: Jun 30
Jul 31, 2026 04:11 PM Context Therapeutics gets Nasdaq minimum bid price deficiency notice
Jul 31, 2026 04:09 PM Form 8-K Context Therapeutics For: Jul 29
View All Articles

Entities mentioned with CNTX

View All Entities